Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY: CRL )

186.65 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Charles River Laboratories
From Bernstein Liebhard LLP
Via GlobeNewswire
Charles River: Q1 Earnings Insights
Via Benzinga
Will Chart Analysts Notice Bad Omen on Charles River's Chart
Via Benzinga
Analyst Ratings for Charles River
Via Benzinga
ROSEN, A LEADING LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Lawsuit
Exposures Financial Legal
Securities Class Action Reminder (NYSE: CRL): Kessler Topaz Meltzer & Check, LLP Reminds Charles River Laboratories International, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Lawsuit
Exposures Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, and Charles River and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Charles River Laboratories International, Inc. (CRL)
From Law Offices of Howard G. Smith
Via Business Wire
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Charles River Laboratories International, Inc. (CRL) Investors
From Kirby McInerney LLP
Via Business Wire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Charles River Laboratories International, Inc. (CRL)
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Charles River Laboratories International, Inc. (CRL) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Charles River Laboratories International, Inc.
From Bernstein Liebhard LLP
Via GlobeNewswire
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Charles River Laboratories International, Inc. (CRL)
From Robbins LLP
Via Business Wire
CHARLES RIVER LABORATORIES SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against Charles River Laboratories International, Inc. - CRL
From Kahn Swick & Foti, LLC
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
CRL EQUITY ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CRL
From The Rosen Law Firm, P.A.
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Charles River Laboratories International, Inc. (CRL) Investors
From Law Offices of Howard G. Smith
Via Business Wire
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Charles River Laboratories International, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
CRL CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Charles River Laboratories International, Inc.
From The Law Offices of Frank R. Cruz
Via Business Wire
CRL CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Charles River Laboratories International, Inc.
From Glancy Prongay & Murray LLP
Via Business Wire
3 DNA Stocks to Buy for the Synthetic Biology Revolution
Synthetic biology is a growing industry. The big winners will be DNA stocks that are able to sell to everyone, not just a small niche. 
Via InvestorPlace
Charles River Laboratories Announces First-Quarter 2023 Results
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID
From Charles River Laboratories International, Inc.
Via Business Wire
3 Healthcare Stocks With Huge Growth Potential
It's been a tough time for the tech industry. So consider these healthcare growth stocks to buy now instead. 
Via InvestorPlace
Bragar Eagel & Squire, P.C. Is Investigating Fox, Charles River, Provident, and Sarepta and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Charles River Laboratories Schedules First-Quarter 2023 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Laboratories Showcases End-to-End Oncology Capabilities at AACR 2023
From Charles River Laboratories International, Inc.
Via Business Wire
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback